Strategic Advocates’s Johnson & Johnson JNJ Stock Holding History

Strategic Advocates’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14	Closed	-$2.9K	–	448
2025 Q4	$2.9K	Hold	14	–	–	﹤0.01%	466
2025 Q3	$2.6K	Buy	+14	New	+$2.4K	﹤0.01%	457

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Strategic Advocates's JNJ Position: Q1 2026 in Review

Strategic Advocates sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 14 shares — an estimated $2.9K sold.

Strategic Advocates first reported a position in JNJ in Q3 2025 and held it in 2 quarters. The position peaked at $2.9K in Q4 2025. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Strategic Advocates reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 14 Johnson & Johnson shares in Q1 2026, an estimated $2.9K.
Strategic Advocates first reported a position in Johnson & Johnson in Q3 2025 and held it in 2 quarters.
Strategic Advocates's Johnson & Johnson position peaked at $2.9K in Q4 2025.
4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.